New Horizon Health Limited (HK:6606) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
New Horizon Health Limited has announced significant changes to its leadership team, including the resignation of Prof. Hong Wu as an independent non-executive Director due to personal health reasons, and the appointment of Ms. Jiangnan Kong in multiple roles, effective from October 1, 2024. Ms. Kong, with a strong legal and business background, steps in as an independent non-executive Director and takes charge of the Remuneration and Nomination Committees. The company has also highlighted the continued suspension of trading.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.